Viridian Therapeutics, Inc. (VRDN)

28.89 -0.51 (-1.73%) USD  |  NASDAQ  |  Feb 25, 15:48
More

Viridian Therapeutics Interest Paid Supplemental Data (Quarterly)

Interest Paid Supplemental Data (Quarterly) Chart

View Interest Paid Supplemental Data (Quarterly) for VRDN.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Interest Paid Supplemental Data (Quarterly) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Interest Paid Supplemental Data (Quarterly) Range, Past 5 Years

View Interest Paid Supplemental Data (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Interest Paid Supplemental Data (Quarterly) Benchmarks

View Interest Paid Supplemental Data (Quarterly) Benchmarks
Start Trial
Marker Therapeutics, Inc. Upgrade
ADMA Biologics, Inc. Upgrade
Avantor, Inc. Upgrade
Immunovant, Inc. Upgrade
Plus Therapeutics, Inc. Upgrade